Curt Staab
SVP, Emerging Life Sciences Network

Curt Staab leads the Emerging Life Sciences Network (elsN), a membership organization for emerging and pre-commercial life sciences companies. A division of TGaS® Advisors, elsN was launched in 2015. Members have access to peer-driven data and insights, answers to operational and strategic issues and advice from peers and industry veterans during the critical early stages of commercialization. Curt has advised over 100 biopharma companies during his 10 year career with TGaS.

Before working with elsN, Curt led the TGaS Sales Advisory Practice, advising Sales Operations leaders across the industry on current and future trends and providing them with fact-based information and actionable insight in such areas as sales force structure, field technology, inside sales, career issues and incentive compensation.

An experienced professional with more than 28 years in pharma. Curt began his career at Merck where he held multiple positions in Sales, Sales Leadership, Marketing and Commercial Operations over an 18 year span. Curt was the Sr. Director of Sales Operations at Merck prior to joining TGaS.


Curt is a graduate of the University of Kansas and holds an MBA from Southern Methodist University.



Connect with Curt


To top